Stocktwits Spotlight: NRx, CVS, ReShape Lead Weekly Jump In Health Care Stock Chatter Favorable regulatory moves for a new drug application, blowout earnings and promising preclinical data triggered a flurry of discussions on Stocktwits for these tickers for the week ended April 11, 2025.
Small-Cap NRx Pharma’s Stock Draws Heavy Retail Buzz After Securing $27M Funding Chairman Jonathan Javitt said the resources committed are expected to bring NRx to the $100 million revenue threshold.
What's Going On With NRX Pharmaceuticals Stock Tuesday? NRX Pharmaceuticals shares are moving higher on Tuesday after it invested $27 million in its subsidiary HOPE Therapeutics.
What's Going On With NRX Pharmaceuticals Stock Thursday? NRX shares are trading higher on Thursday after the company announced a joint acquisition initiative with Hope Therapeutics to buy Kadima Neuropsychiatry Institute.
NRXP Stock Earnings: NRX Pharmaceuticals Misses EPS for Q2 2024 NRXP stock results show that NRX Pharmaceuticals missed analyst estimates for earnings per share the second quarter of 2024.
NRXP Stock Earnings: NRX Pharmaceuticals Misses EPS for Q1 2024 NRXP stock results show that NRX Pharmaceuticals missed analyst estimates for earnings per share the first quarter of 2024.
Why Is NRx Pharmaceuticals Stock Falling After Data From Suicidal Bipolar Depression Study NRX Pharmaceuticals announces Phase 2b/3 trial findings of NRX-101 vs. Lurasidone for Suicidal Bipolar Depression.
Why Is Bio-Path (BPTH) Stock Up 89% Today? Bio-Path stock is up with heavy trading of BPTH shares today alongside positive news from its ongoing clinical trial of BP1002.
